Halfpenny Technologies Demonstrates True Interoperability for Molecular Testing at MDx NEXT 2013 Conference

Halfpenny Technologies Demonstrates True Interoperability for Molecular Testing at MDx NEXT 2013 Conference

Halfpenny TechnologiesPatricia BrownDirector of Marketing610-277-9100 ext. 187

Halfpenny Technologies is pleased to showcase its truly interoperable, clinical data exchange solution for molecular laboratories at the MDx NEXT Conference in Las Vegas, NV from June 12-14. The event sponsored by G2 Intelligence will focus on how hospitals and independent laboratories can successfully integrate molecular diagnostic testing into their business strategies.

“For hospitals and independent laboratories, integrated CPOE and clinical data exchange can produce significant improvement in outcomes when combined with business intelligence which depicts the flow of clinical data,” President and CEO of Halfpenny Technologies Tim Kowalski said. “By making clinical data actionable, Halfpenny Technologies gives labs the tools they need to better improve overall efficiency, coordination of care, and competitiveness in the market.”

Halfpenny Technologies’ true interoperability solutions empower molecular laboratories with better care coordination & customer outreach by offering tools that:

The combination of tools allows molecular laboratories to better understand the flow of clinical data, enabling them to become more efficient and competitive in the market.

Held at the Westin Las Vegas Hotel Casino and Spa, the G2 conference offers sessions, case studies and discussions on realizing molecular diagnostics as a profit source within genomic medicine, focusing on where the market is going in 2013 and beyond and how leading molecular labs are expanding.

. provides clinical laboratories, hospitals, health plans, accountable care organizations (ACOs), health information exchanges (HIEs) and EHR vendors with a cloud based, secure, scalable, vendor-neutral designed to optimize care coordination. Our proven track record of providing advanced features, rapid implementation, reliable technology infrastructure and enables laboratories and hospitals to win new clients and better compete in the HITECH era; health plans to improve HEDIS reporting and STAR ratings, increase revenue and support population-based initiatives; and to include CPOE and results delivery in their solutions and meet Meaningful Use certification requirements.

To learn more about Halfpenny Technologies visit the web site: .

Suggested Articles

Genealogy company Ancestry is expanding into genetic health testing, ramping up competition with 23andMe.

Most healthcare organizations are lagging in awareness and preparedness for compliance with proposed interoperability rules, according to a survey.

Medical Group Management Association officials got out their crystal ball Monday.